Listed

Arbutus Biopharma Corp: Form 8-K/A, filed Mar 20, 2017

Filed with the SEC on Mar 20, 2017 and accepted by EDGAR at Mar 20, 2017, 15:00 ET.

Share

Items reported

  • Item 1.01 Entry into a material agreement

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001628280-17-002711. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.